CFLAR and colorectal carcinoma: Analogously to the effects observed for vorinostat, basal and selumetinib-induced expression of c-FLIPL was downregulated in BRAF-mutant CRC by treatment with the class I selective HDAC1-3 inhibitor entinostat, leading to caspase-8 dependent apoptosis induction.